Publications by authors named "Patrick Robberecht"

Claim this Profile
S
Spatial proximity between the VPAC1 receptor and the amino terminus of agonist and antagonist peptides reveals distinct sites of interaction.
Emilie Ceraudo, Régine Hierso, Yossan-Var Tan, Samuel Murail, Christiane Rouyer-Fessard, Patrick Robberecht

FASEB J· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VIP blockade leads to microcephaly in mice via disruption of Mcph1-Chk1 signaling.
Sandrine Passemard, Vincent El Ghouzzi, Hala Nasser, Catherine Verney, Guilan Vodjdani, Patrick Robberecht

J Clin Invest· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence for a direct and functional interaction between the regulators of G protein signaling-2 and phosphorylated C terminus of cholecystokinin-2 receptor.
Ingrid Langer, Irina G Tikhonova, Cyril Boulègue, Jean-Pierre Estève, Sébastien Vatinel, Patrick Robberecht

Mol Pharmacol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell surface targeting of VPAC1 receptors: evidence for implication of a quality control system and the proteasome.
Ingrid Langer, Karelle Leroy, Nathalie Gaspard, Jean-Pierre Brion, Patrick Robberecht

Biochim Biophys Acta· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of positive charge in VIP 16gamma-glutamyl diamino derivatives on hVPAC1 and hVPAC2 receptor function.
Salvatore de Maria, Vittoria Metafora, Salvatore Metafora, Gianpietro Ravagnan, Maria Cartení, Patrick Robberecht

J Pept Sci· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
Ingrid Nachtergael, Nathalie Gaspard, Christelle Langlet, Patrick Robberecht, Ingrid Langer

Cell Signal· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2).
Ingrid Langer, Nathalie Gaspard, Patrick Robberecht

Br J Pharmacol· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation of the phosphorylatable residue Thr429 in Glu of the human VPAC1 led to a constitutively desensitized receptor.
Christelle Langlet, Ingrid Nachtergael, Patrick Robberecht, Ingrid Langer

Peptides· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Motilin and erythromycin-A share a common binding site in the third transmembrane segment of the motilin receptor.
Luo Xu, Inge Depoortere, Pascale Vertongen, Magali Waelbroeck, Patrick Robberecht

Biochem Pharmacol· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contribution of the carboxyl terminus of the VPAC1 receptor to agonist-induced receptor phosphorylation, internalization, and recycling.
Christelle Langlet, Ingrid Langer, Pascale Vertongen, Nathalie Gaspard, Jean-Marie Vanderwinden, Patrick Robberecht

J Biol Chem· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Desensitization of the human motilin receptor by motilides.
Leen Thielemans, Inge Depoortere, Jason Perret, Patrick Robberecht, Yaoquan Liu

J Pharmacol Exp Ther· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antisecretory actions of a novel vasoactive intestinal polypeptide (VIP) antagonist in human and rat small intestine.
Matthew R Banks, Michael J G Farthing, Patrick Robberecht, David E Burleigh

Br J Pharmacol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of inactivating mutations on phosphorylation and internalization of the human VPAC2 receptor.
Ingrid Langer, Christelle Langlet, Patrick Robberecht

J Mol Endocrinol· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ghrelin is produced by the human erythroleukemic HEL cell line and involved in an autocrine pathway leading to cell proliferation.
Carine De Vriese, Françoise Grégoire, Philippe De Neef, Patrick Robberecht, Christine Delporte

Endocrinology· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in the carboxy-terminus of the third intracellular loop of the human recombinant VPAC1 receptor impair VIP-stimulated [Ca2+]i increase but not adenylate cyclase stimulation.
Ingrid Langer, Patrick Robberecht

Cell Signal· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and characterization of an endogenous chemotactic ligand specific for FPRL2.
Isabelle Migeotte, Elena Riboldi, Jean-Denis Franssen, Françoise Grégoire, Cécile Loison, Patrick Robberecht

J Exp Med· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy of VIP and analogs on activation and internalization of the recombinant VPAC2 receptor expressed in CHO cells.
Christelle Langlet, Nathalie Gaspard, Ingrid Nachtergael, Patrick Robberecht, Ingrid Langer

Peptides· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Ghrelin degradation by serum and tissue homogenates: identification of the cleavage sites.
Carine De Vriese, Francoise Gregoire, Roger Lema-Kisoka, Magali Waelbroeck, Patrick Robberecht

Endocrinology· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ac His1 [D-Phe2, K15, R16, L27] VIP (3-7)/GRF (8-27)--a VPAC1 receptor antagonist--is an inverse agonist on two constitutively active truncated VPAC1 receptors.
Pascale Vertongen, Christelle Langlet, Ingrid Langer, Nathalie Gaspard, Patrick Robberecht

Peptides· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibitory pathways in the circular muscle of rat jejunum.
Gwen Vanneste, Patrick Robberecht, Romain A Lefebvre

Br J Pharmacol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ala-scan of ghrelin (1-14): interaction with the recombinant human ghrelin receptor.
Mélanie Van Craenenbroeck, Françoise Gregoire, Philippe De Neef, Patrick Robberecht, Jason Perret

Peptides· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coexistence of non-adrenergic non-cholinergic inhibitory and excitatory neurotransmitters in a large neuronal subpopulation in the vaginal segment of the chicken oviduct.
Anna Costagliola, Joris G De Man, Mariusz Majewski, Mirek Lakomy, Aldo Cecio, Patrick Robberecht

Auton Neurosci· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency.
Valérie Wittamer, Françoise Grégoire, Patrick Robberecht, Gilbert Vassart, David Communi

J Biol Chem· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hexanoylation of a VPAC2 receptor-preferring ligand markedly increased its selectivity and potency.
Ingrid Langer, Françoise Gregoire, Ingrid Nachtergael, Philippe De Neef, Pascale Vertongen, Patrick Robberecht

Peptides· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of the growth hormone-releasing peptides ghrelin and growth hormone-releasing peptide-6 with the motilin receptor in the rabbit gastric antrum.
Inge Depoortere, Theo Thijs, Leen Thielemans, Patrick Robberecht, Theo L Peeters

J Pharmacol Exp Ther· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis